Patient survival for all cancers combined as indicator of cancer control in Europe

Arduino Verdecchia, Paolo Baili, Alberto Quaglia, Ian Kunkler, Roberta Ciampichini, Franco Berrino, Andrea Micheli

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Background: EUROCARE found marked differences in cancer survival across European populations, provoking extensive discussion as to the cause. We investigated the influence of socioeconomic indicators on survival, making use of the indicator population-based age-standardized and cancer site-standardized relative survival for all cancers combined (all cancer survival). Methods: Bivariate correlation and multivariate regression analyses investigated relations between 1995 socioeconomic variables and all cancer survival in EUROCARE-3 patients from 19 European countries diagnosed 1990-94 and followed to 1999. Results: Gross domestic product (GDP) and total national expenditure on health (TNEH) correlated highly with all cancer survival. Wealthy northern and western European countries had high survival; eastern European countries had low all cancer survival. GDP, TNEH, and number of computed tomography scanners per million - proxy of technological investment in cancer care - explained most survival differences. Low all cancer survival in the UK and Denmark compared to countries of similar wealth was closely related to fewer computed tomography scanners. Low all cancer survival in Poland compared to countries of similar wealth was also related to low TNEH. Conclusions: All cancer survival appears a useful and important indicator for monitoring countries' performance in cancer control. The most direct way for poorer European countries to improve all cancer survival would be to get richer; for richer countries more investment in health technology is important. However the sharply increasing costs of cancer care may render this impossible suggesting the need to radically rethink cancer control strategies.

Original languageEnglish
Pages (from-to)527-532
Number of pages6
JournalEuropean Journal of Public Health
Volume18
Issue number5
DOIs
Publication statusPublished - Oct 2008

Fingerprint

Survival
Neoplasms
Health Expenditures
X-Ray Computed Tomography Scanners
Gross Domestic Product
Biomedical Technology
Proxy
Poland
Denmark
Population
Multivariate Analysis
Regression Analysis
Costs and Cost Analysis

Keywords

  • Cancer control
  • Cancer indicator
  • Cancer survival
  • EUROCARE
  • EUROCHIP

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Verdecchia, A., Baili, P., Quaglia, A., Kunkler, I., Ciampichini, R., Berrino, F., & Micheli, A. (2008). Patient survival for all cancers combined as indicator of cancer control in Europe. European Journal of Public Health, 18(5), 527-532. https://doi.org/10.1093/eurpub/ckn022

Patient survival for all cancers combined as indicator of cancer control in Europe. / Verdecchia, Arduino; Baili, Paolo; Quaglia, Alberto; Kunkler, Ian; Ciampichini, Roberta; Berrino, Franco; Micheli, Andrea.

In: European Journal of Public Health, Vol. 18, No. 5, 10.2008, p. 527-532.

Research output: Contribution to journalArticle

Verdecchia, A, Baili, P, Quaglia, A, Kunkler, I, Ciampichini, R, Berrino, F & Micheli, A 2008, 'Patient survival for all cancers combined as indicator of cancer control in Europe', European Journal of Public Health, vol. 18, no. 5, pp. 527-532. https://doi.org/10.1093/eurpub/ckn022
Verdecchia A, Baili P, Quaglia A, Kunkler I, Ciampichini R, Berrino F et al. Patient survival for all cancers combined as indicator of cancer control in Europe. European Journal of Public Health. 2008 Oct;18(5):527-532. https://doi.org/10.1093/eurpub/ckn022
Verdecchia, Arduino ; Baili, Paolo ; Quaglia, Alberto ; Kunkler, Ian ; Ciampichini, Roberta ; Berrino, Franco ; Micheli, Andrea. / Patient survival for all cancers combined as indicator of cancer control in Europe. In: European Journal of Public Health. 2008 ; Vol. 18, No. 5. pp. 527-532.
@article{0c4de66be9404f18b1c94f54b64cf6fa,
title = "Patient survival for all cancers combined as indicator of cancer control in Europe",
abstract = "Background: EUROCARE found marked differences in cancer survival across European populations, provoking extensive discussion as to the cause. We investigated the influence of socioeconomic indicators on survival, making use of the indicator population-based age-standardized and cancer site-standardized relative survival for all cancers combined (all cancer survival). Methods: Bivariate correlation and multivariate regression analyses investigated relations between 1995 socioeconomic variables and all cancer survival in EUROCARE-3 patients from 19 European countries diagnosed 1990-94 and followed to 1999. Results: Gross domestic product (GDP) and total national expenditure on health (TNEH) correlated highly with all cancer survival. Wealthy northern and western European countries had high survival; eastern European countries had low all cancer survival. GDP, TNEH, and number of computed tomography scanners per million - proxy of technological investment in cancer care - explained most survival differences. Low all cancer survival in the UK and Denmark compared to countries of similar wealth was closely related to fewer computed tomography scanners. Low all cancer survival in Poland compared to countries of similar wealth was also related to low TNEH. Conclusions: All cancer survival appears a useful and important indicator for monitoring countries' performance in cancer control. The most direct way for poorer European countries to improve all cancer survival would be to get richer; for richer countries more investment in health technology is important. However the sharply increasing costs of cancer care may render this impossible suggesting the need to radically rethink cancer control strategies.",
keywords = "Cancer control, Cancer indicator, Cancer survival, EUROCARE, EUROCHIP",
author = "Arduino Verdecchia and Paolo Baili and Alberto Quaglia and Ian Kunkler and Roberta Ciampichini and Franco Berrino and Andrea Micheli",
year = "2008",
month = "10",
doi = "10.1093/eurpub/ckn022",
language = "English",
volume = "18",
pages = "527--532",
journal = "European Journal of Public Health",
issn = "1101-1262",
publisher = "NLM (Medline)",
number = "5",

}

TY - JOUR

T1 - Patient survival for all cancers combined as indicator of cancer control in Europe

AU - Verdecchia, Arduino

AU - Baili, Paolo

AU - Quaglia, Alberto

AU - Kunkler, Ian

AU - Ciampichini, Roberta

AU - Berrino, Franco

AU - Micheli, Andrea

PY - 2008/10

Y1 - 2008/10

N2 - Background: EUROCARE found marked differences in cancer survival across European populations, provoking extensive discussion as to the cause. We investigated the influence of socioeconomic indicators on survival, making use of the indicator population-based age-standardized and cancer site-standardized relative survival for all cancers combined (all cancer survival). Methods: Bivariate correlation and multivariate regression analyses investigated relations between 1995 socioeconomic variables and all cancer survival in EUROCARE-3 patients from 19 European countries diagnosed 1990-94 and followed to 1999. Results: Gross domestic product (GDP) and total national expenditure on health (TNEH) correlated highly with all cancer survival. Wealthy northern and western European countries had high survival; eastern European countries had low all cancer survival. GDP, TNEH, and number of computed tomography scanners per million - proxy of technological investment in cancer care - explained most survival differences. Low all cancer survival in the UK and Denmark compared to countries of similar wealth was closely related to fewer computed tomography scanners. Low all cancer survival in Poland compared to countries of similar wealth was also related to low TNEH. Conclusions: All cancer survival appears a useful and important indicator for monitoring countries' performance in cancer control. The most direct way for poorer European countries to improve all cancer survival would be to get richer; for richer countries more investment in health technology is important. However the sharply increasing costs of cancer care may render this impossible suggesting the need to radically rethink cancer control strategies.

AB - Background: EUROCARE found marked differences in cancer survival across European populations, provoking extensive discussion as to the cause. We investigated the influence of socioeconomic indicators on survival, making use of the indicator population-based age-standardized and cancer site-standardized relative survival for all cancers combined (all cancer survival). Methods: Bivariate correlation and multivariate regression analyses investigated relations between 1995 socioeconomic variables and all cancer survival in EUROCARE-3 patients from 19 European countries diagnosed 1990-94 and followed to 1999. Results: Gross domestic product (GDP) and total national expenditure on health (TNEH) correlated highly with all cancer survival. Wealthy northern and western European countries had high survival; eastern European countries had low all cancer survival. GDP, TNEH, and number of computed tomography scanners per million - proxy of technological investment in cancer care - explained most survival differences. Low all cancer survival in the UK and Denmark compared to countries of similar wealth was closely related to fewer computed tomography scanners. Low all cancer survival in Poland compared to countries of similar wealth was also related to low TNEH. Conclusions: All cancer survival appears a useful and important indicator for monitoring countries' performance in cancer control. The most direct way for poorer European countries to improve all cancer survival would be to get richer; for richer countries more investment in health technology is important. However the sharply increasing costs of cancer care may render this impossible suggesting the need to radically rethink cancer control strategies.

KW - Cancer control

KW - Cancer indicator

KW - Cancer survival

KW - EUROCARE

KW - EUROCHIP

UR - http://www.scopus.com/inward/record.url?scp=48049095548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48049095548&partnerID=8YFLogxK

U2 - 10.1093/eurpub/ckn022

DO - 10.1093/eurpub/ckn022

M3 - Article

VL - 18

SP - 527

EP - 532

JO - European Journal of Public Health

JF - European Journal of Public Health

SN - 1101-1262

IS - 5

ER -